| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/23/2004 | EP1429803A2 Anti-coronavirus vaccine |
| 06/23/2004 | EP1429802A1 Delivery system for biological component |
| 06/23/2004 | EP1429801A1 Neuropilin as a novel therapeutic target for modulation of immune reponses |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429774A2 Stent coated with a substained-release drug delivery |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429750A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP0983251B1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 06/23/2004 | EP0980359B1 Benzimidazole derivative |
| 06/23/2004 | CN1507491A Apoptosis promoter and inhibitor interacting with CGI-94 and method of screening the same |
| 06/23/2004 | CN1507452A Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507353A Compositions for use in treating IGE-associated disorders |
| 06/23/2004 | CN1507349A Medicaments containing a polyamine as an active substance |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1506376A Embedded CD25-resisting monoclonal antibody and its coding sequence and application |
| 06/23/2004 | CN1506365A Prepn process of tripterygium extractive |
| 06/23/2004 | CN1506116A Process for preparing degradable polymer and medical composition containing the said polymer and use thereof |
| 06/23/2004 | CN1506075A Cell growth regulating factor V and its prepn process |
| 06/23/2004 | CN1506066A Cell growth regulating factor oral liquid and its prepn process |
| 06/23/2004 | CN1506065A Cell growth regulating factor D and its prepn process |
| 06/23/2004 | CN1506064A Cell growth regulating factor E and its prepn process |
| 06/23/2004 | CN1506063A Cell growth regulatnig factor F and its prepn process |
| 06/23/2004 | CN1506062A Cell growth regulating factor G and its prepn process |
| 06/23/2004 | CN1506061A Cell growth regulating factor II and its prepn process |
| 06/23/2004 | CN1506060A Cell growth regulating factor I and its prepn process |
| 06/23/2004 | CN1506059A Cell growth regulating factor K and its prepn process |
| 06/23/2004 | CN1506058A Cell growth regulating factor O and its prepn process |
| 06/23/2004 | CN1506057A Cell growth regulating factor Q and its prepn process |
| 06/23/2004 | CN1506056A Cell growth regulating factor R and its prepn process |
| 06/23/2004 | CN1506055A Cell growth regulatnig factor S and its prepn process |
| 06/23/2004 | CN1506054A Cell growth regulating factor U and its prepn process |
| 06/23/2004 | CN1506053A Cell growth regulating factor W and its prepn process |
| 06/23/2004 | CN1506052A Cell growth regulating factor X and its prepn process |
| 06/23/2004 | CN1505977A Nutritious constituents |
| 06/23/2004 | CN1154653C Peptide and method of obtaining it |
| 06/23/2004 | CN1154652C 5-imino-13-doxy anthracycline derivatives, their uses, and processes for preparing them |
| 06/23/2004 | CN1154647C Imidazonephthyridines and their use in inducing cytokine biosynthesis |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154506C Method of preventing or treating allergies |
| 06/23/2004 | CN1154500C Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154492C Medical composition containing pentosan polysulfate and its application |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154488C Immuno inhibitort |
| 06/22/2004 | US6753427 2,6-disubstituted 7-oxopyrido(2,3-d)pyrimidines; inhibitors of protein kinases; treating diseases mediated by the pro-inflammatory cytokines, e.g., tumor necrosis factor, inter-leukins, cycloxygenase; chronic obstructive pulmonary disease |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/22/2004 | CA2114113C Cardiac output probe assembly |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050096A2 Phosphoantigens for regulating an immune response |
| 06/17/2004 | WO2004050094A1 Use of levocetirizine for the treatment of persistent allergic rhinitis |
| 06/17/2004 | WO2004050090A1 Rapamycin and il-10 for the treatment of immune diseases |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050079A1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 06/17/2004 | WO2004050052A1 Oxazolidinones for cosmetic and pharmaceutical use in skin pathologies |
| 06/17/2004 | WO2004032911A3 Styrylacrylonitrile compounds for inhibition of vascular endothelial growth factor |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003073351A3 Screening process |
| 06/17/2004 | WO2003066072A3 Cell therapy using immunoregulatory t-cells |
| 06/17/2004 | WO2003037308A8 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | US20040116738 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116519 Anticholinergic agents such as 4-(diethylmethylaminium)-2-butynyl alpha phenyl cyclohexane glycolate iodide, used for prophylaxis of asthma, chronic obstructive pulmonary disease and rhinitis |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116461 Immunomodulatory compounds |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116426 Small molecules useful in the treatment of inflammatory disease |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116416 having immunomodulating and cytokine-release-inhibiting action |